Published in Nature on July 20, 2000
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest (2007) 4.41
Stem cells and liver regeneration. Gastroenterology (2009) 3.40
The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A (2003) 2.99
HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest (2003) 2.89
Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther (2002) 2.63
Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology (2008) 2.31
Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A (2003) 2.20
Kinetics of liver repopulation after bone marrow transplantation. Am J Pathol (2002) 1.85
Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am J Pathol (2003) 1.69
Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut (2002) 1.60
Activation of stem cells in hepatic diseases. Cell Tissue Res (2007) 1.59
Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med (2009) 1.58
Stem cells as a potential future treatment of pediatric intestinal disorders. J Pediatr Surg (2008) 1.57
From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B Biol Sci (2002) 1.56
New concepts in liver regeneration. J Gastroenterol Hepatol (2011) 1.55
Stem cells and the pathogenesis of endometriosis. Ann N Y Acad Sci (2008) 1.49
Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of the transplanted cells in the injured liver. J Gastroenterol (2006) 1.46
Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest (2002) 1.41
Bone marrow stem cells and liver disease. Gut (2006) 1.40
Cancer stem cells: the lessons from pre-cancerous stem cells. J Cell Mol Med (2007) 1.38
Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta (2007) 1.37
Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol (2006) 1.37
C1qRp defines a new human stem cell population with hematopoietic and hepatic potential. Proc Natl Acad Sci U S A (2002) 1.26
Bone marrow production of lung cells: the impact of G-CSF, cardiotoxin, graded doses of irradiation, and subpopulation phenotype. Exp Hematol (2006) 1.20
Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol (2007) 1.20
Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol (2012) 1.18
Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo. Gut (2005) 1.18
Stem cell properties and repopulation of the rat liver by fetal liver epithelial progenitor cells. Am J Pathol (2001) 1.18
Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology (2007) 1.17
Endothelial differentiation of mesenchymal stromal cells. PLoS One (2012) 1.14
Cell lineage analysis of the mammalian female germline. PLoS Genet (2012) 1.13
Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response. J Gastroenterol (2005) 1.12
The new stem cell biology: something for everyone. Mol Pathol (2003) 1.10
Therapeutic potential of bone marrow-derived mesenchymal stem cells for cutaneous wound healing. Front Immunol (2012) 1.08
Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1. Am J Pathol (2002) 1.07
Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver. PLoS One (2009) 1.07
Epithelial tissue chimerism after human hematopoietic cell transplantation is a real phenomenon. Am J Pathol (2004) 1.07
Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med (2006) 1.07
The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3. Am J Pathol (2002) 1.07
Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res (2011) 1.06
Participation of adult mouse bone marrow cells in reconstitution of skin. Am J Pathol (2003) 1.05
Liver-specific gene expression in mesenchymal stem cells is induced by liver cells. World J Gastroenterol (2005) 1.03
Self-organization vs Watchmaker: stochastic gene expression and cell differentiation. Dev Genes Evol (2004) 1.02
Hepatic stem cells: existence and origin. World J Gastroenterol (2003) 1.02
Therapeutic implications of mesenchymal stem cells in liver injury. J Biomed Biotechnol (2011) 1.02
Development of cell therapy using autologous bone marrow cells for liver cirrhosis. Med Mol Morphol (2005) 1.02
Transdifferentiation, metaplasia and tissue regeneration. Organogenesis (2004) 1.02
Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury. Int J Exp Pathol (2006) 1.01
Ischemia/reperfusion injury promotes and granulocyte-colony stimulating factor inhibits migration of bone marrow-derived stem cells to endometrium. Stem Cells Dev (2012) 0.99
Stem cells for liver tissue repair: current knowledge and perspectives. World J Gastroenterol (2008) 0.99
Myeloid-specific IκB kinase β deficiency decreases atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol (2012) 0.98
Artificial cell microencapsulated stem cells in regenerative medicine, tissue engineering and cell therapy. Adv Exp Med Biol (2010) 0.98
Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol (2006) 0.97
Hepatocyte transplantation for inborn errors of metabolism. J Inherit Metab Dis (2004) 0.96
Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver. Am J Pathol (2005) 0.96
Liver repopulation for the treatment of metabolic diseases. J Inherit Metab Dis (2001) 0.95
Liver bioengineering: current status and future perspectives. World J Gastroenterol (2012) 0.95
Stem cells in liver regeneration and therapy. Cell Tissue Res (2007) 0.95
Mesenchymal stem cell therapy for liver fibrosis. Korean J Intern Med (2015) 0.95
Hepatocyte progenitors in man and in rodents--multiple pathways, multiple candidates. Int J Exp Pathol (2005) 0.95
Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis. J Mol Cell Cardiol (2008) 0.94
Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells. Int J Biochem Cell Biol (2010) 0.94
Young adult donor bone marrow infusions into female mice postpone age-related reproductive failure and improve offspring survival. Aging (Albany NY) (2008) 0.93
Practical Modeling Concepts for Connective Tissue Stem Cell and Progenitor Compartment Kinetics. J Biomed Biotechnol (2003) 0.93
Hepatic differentiation capability of rat bone marrow-derived mesenchymal stem cells and hematopoietic stem cells. World J Gastroenterol (2004) 0.92
Upregulation of lymphotoxin beta expression in liver progenitor (oval) cells in chronic hepatitis C. Gut (2003) 0.92
Mesenchymal stem cell-derived hepatocytes for functional liver replacement. Front Immunol (2012) 0.91
Stem cells in endometrium and their role in the pathogenesis of endometriosis. Ann N Y Acad Sci (2011) 0.91
Potentials of regenerative medicine for liver disease. Surg Today (2009) 0.90
Selection, proliferation and differentiation of bone marrow-derived liver stem cells with a culture system containing cholestatic serum in vitro. World J Gastroenterol (2004) 0.89
Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects. World J Gastroenterol (2015) 0.89
Stem cells in the adult pancreas and liver. Biochem J (2007) 0.88
Cigarette smoke inhibits recruitment of bone-marrow-derived stem cells to the uterus. Reprod Toxicol (2010) 0.87
Stem cells: potency, plasticity and public perception. J Anat (2002) 0.87
Autologous bone marrow stem cells in the treatment of chronic liver disease. Int J Hepatol (2011) 0.86
Bone marrow derived stem cells for the treatment of end-stage liver disease. World J Gastroenterol (2014) 0.86
Plasticity and maintenance of hematopoietic stem cells during development. Recent Pat Biotechnol (2011) 0.85
Efficiency of bone marrow-derived cells in regeneration of the stomach after induction of ethanol-induced ulcers in rats. J Gastroenterol (2005) 0.84
Adipose tissue-derived mesenchymal stem cells differentiated into hepatocyte-like cells in vivo and in vitro. Mol Med Rep (2014) 0.84
Roles of p53 in various biological aspects of hematopoietic stem cells. J Biomed Biotechnol (2012) 0.84
Virus-related liver cirrhosis: molecular basis and therapeutic options. World J Gastroenterol (2014) 0.83
Intestinal metaplasia -the effect of Acid on the gastric mucosa and gastric carcinogenesis-. J Toxicol Pathol (2010) 0.82
Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives. World J Gastroenterol (2015) 0.82
Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury. J Biomed Biotechnol (2011) 0.82
Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regeneration. World J Gastroenterol (2014) 0.82
Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroenterol (2013) 0.82
Bone marrow-derived hepatocytes : rare but promising. Am J Pathol (2002) 0.81
Therapy with bone marrow cells reduces liver alterations in mice chronically infected by Schistosoma mansoni. World J Gastroenterol (2008) 0.81
Artificial liver support at present and in the future. J Artif Organs (2006) 0.80
New insights in hepatocellular carcinoma: from bench to bedside. Ann Transl Med (2013) 0.80
Mobilization of hematopoietic progenitor cells in patients with liver cirrhosis. World J Gastroenterol (2010) 0.80
Ameliorative effect of bone marrow-derived stem cells on injured liver of mice infected with Schistosoma mansoni. Korean J Parasitol (2014) 0.80
Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients. J Gastroenterol (2011) 0.80
The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency. Stem Cell Res Ther (2015) 0.79
Identification of cancer stem cell subpopulations of CD34(+) PLC/PRF/5 that result in three types of human liver carcinomas. Stem Cells Dev (2015) 0.79
Osteogenic potential of adult stem cells from human maxillary sinus membrane by Simvastatin in vitro: preliminary report. J Korean Assoc Oral Maxillofac Surg (2013) 0.79
Differentiation of human umbilical cord blood stem cells into hepatocytes in vivo and in vitro. World J Gastroenterol (2006) 0.79
Stem cell differentiation and human liver disease. World J Gastroenterol (2012) 0.79
Stem cell therapy for inherited metabolic disorders of the liver. Exp Hematol (2008) 0.79
Differentiation of hepatocytoid cell induced from whole-bone-marrow method isolated rat myeloid mesenchymal stem cells. World J Gastroenterol (2006) 0.78
Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest (1998) 6.76
Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70
Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing (1980) 4.30
Linkage analysis of quantitative traits: increased power by using selected samples. Am J Hum Genet (1991) 4.23
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother (2011) 4.21
Normal rubbish: deviant patients in casualty departments. Sociol Health Illn (1979) 4.20
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet (2005) 4.12
Evaluation of early diagnostic services for the elderly. Br Med J (1970) 4.00
National character does not reflect mean personality trait levels in 49 cultures. Science (2005) 3.56
Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J Cell Sci (2000) 3.50
Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother (1999) 3.29
The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol (1990) 3.23
A review of current literature on the impact of HIV/AIDS on children in sub-Saharan Africa. AIDS (2000) 3.23
Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol (2001) 3.04
An evaluation of home visiting of patients by physicians in geriatric medicine. Br Med J (Clin Res Ed) (1981) 3.04
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88
T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol (1997) 2.76
Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trial. Pediatrics (2000) 2.72
Granulomatous vasculitis in Crohn's disease. Gastroenterology (1991) 2.72
A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol (1991) 2.71
Old people and their relatives. Lancet (1966) 2.61
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut (2008) 2.51
Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med (1998) 2.45
Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem (1985) 2.45
Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes (1998) 2.44
Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis (1967) 2.43
PGP 9.5--a new marker for vertebrate neurons and neuroendocrine cells. Brain Res (1983) 2.41
Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity (2000) 2.40
The human polycomb group complex associates with pericentromeric heterochromatin to form a novel nuclear domain. J Cell Biol (1998) 2.29
Method of sampling in a study of older people with a comparison of respondents and non-respondents. Br J Prev Soc Med (1971) 2.29
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol (1990) 2.29
Review article: the investigation and management of gastric neuroendocrine tumours. Aliment Pharmacol Ther (2014) 2.28
Drug-induced parkinsonism in the elderly. Lancet (1984) 2.27
Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet (1990) 2.22
Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science (1996) 2.22
The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med (1995) 2.20
Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest (1999) 2.10
A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem (1999) 2.09
Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08
I-cell disease: biochemical studies. Pediatr Res (1972) 2.08
[Evaluation of the degree of adherence to the Mediterranean diet in patients with heart failure: DIME-EAHFE study]. An Sist Sanit Navar (2016) 2.05
The changing face of ectopic pregnancy. BMJ (1997) 2.03
Weight loss treatment influences untreated spouses and the home environment: evidence of a ripple effect. Int J Obes (Lond) (2008) 2.02
Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01
Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver (1999) 2.01
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology (1993) 1.97
PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology (1985) 1.97
E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol (1993) 1.89
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Telephone triage and consultation: an emerging role for nurses. Nurs Outlook (1999) 1.86
Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol (1993) 1.84
Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis (1999) 1.84
A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA (2001) 1.82
A statistical aid to the diagnosis of keratoconjunctivitis sicca. Q J Med (1972) 1.81
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol (1997) 1.80
Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol (1993) 1.78
Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76
QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma. J Pathol (1990) 1.76
The effect of starvation and refeeding on cell population kinetics in the rat small bowel mucosa. J Anat (1975) 1.73
APC in the regulation of intestinal crypt fission. J Pathol (1998) 1.73
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Br J Dermatol (2001) 1.70
Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci U S A (1998) 1.70
ENCORE: the effect of nutrient enrichment on coral reefs. Synthesis of results and conclusions. Mar Pollut Bull (2001) 1.69
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69
Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet (2001) 1.68
The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol (1988) 1.67
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut (1988) 1.67
Clinical and laboratory features and response to treatment in patients presenting with vitamin B12 deficiency-related neurological syndromes. Neurol India (2005) 1.66
Crypt fission in the small intestine and colon. A mechanism for the emergence of G6PD locus-mutated crypts after treatment with mutagens. Am J Pathol (1995) 1.64
Sjögren's syndrome and thyroid disease. Br J Ophthalmol (1967) 1.64
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer. Gut (2010) 1.63
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
The kinetics of villus cell populations in the mouse small intestine. I. Normal villi: the steady state requirement. Cell Tissue Kinet (1982) 1.60
Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut (2002) 1.60
Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut (2000) 1.59
Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. Genomics (1995) 1.59
Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol (2014) 1.57
Stem cell in gastrointestinal structure and neoplastic development. Gut (2004) 1.57
The metaphase arrest technique. A critical review. Cell Tissue Kinet (1980) 1.57
Wnt5a cloning, expression, and up-regulation in human primary breast cancers. Clin Cancer Res (1995) 1.56
The ulcer-associated cell lineage: the gastrointestinal repair kit? J Pathol (1993) 1.56
Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol (1970) 1.56
Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology (1993) 1.55
The stem cells of small intestinal crypts: where are they? Cell Prolif (2009) 1.55
Support for restrictive tobacco policies among residents of selected Minnesota communities. Am J Health Promot (1993) 1.53
Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol (1999) 1.53
Mode of cell wall growth of Bacillus megaterium. J Bacteriol (1972) 1.52